Seattle, WA · Founded 2018 · Privately Held (backing)
Developer of a microscopy imaging system designed to analyze images of complex and morphological structures of tissue samples. Alpenglow Biosciences is based in Seattle, WA and was founded in 2018. Its last reported valuation was $14.6 million in Jun 2021. It has raised $9.8 million across 1 recorded round; the latest was a $3 million seed round in Mar 2024.
Last reported valuation
$14.6M
Oct 2026
Priced at
—
Total raised
$9.8M
Last round
Seed Round
Mar 2024
No prints on record
No secondary trades in Alpenglow Biosciences shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Alpenglow Biosciences with a free account
·The complete investor list: 12 names
·Watch Alpenglow Biosciences: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Alpenglow Biosciences stock.
